Merck India appoints Pratima Reddy as Country Speaker
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
The identified products for Active Pharmaceutical Ingredients (API) will be developed under the CRAMS and CDMO models
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
New reforestation projects in Brazil, India, Vietnam, Ghana and Rwanda in addition to existing projects including in Australia and Indonesia
Survodutide has a novel mechanism of action (agonism of the dual GCG/GLP-1 receptors) that may have direct effects on energy expenditure in the liver in addition to decreasing appetite
Lilly to further investigate retatrutide for the treatment of obesity in the TRIUMPH phase 3 clinical program
LITFULO is the first and only treatment for severe alopecia areata approved for patients as young as 12
The company will submit its comprehensive response on these observations to the USFDA
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Subscribe To Our Newsletter & Stay Updated